HCA Healthcare (NYSE:HCA) updated its FY19 earnings guidance on Tuesday. The company provided EPS guidance of $9.80-10.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $10.03. The company issued revenue guidance of $50.5-51.5 billion, compared to the consensus revenue estimate of $50.77 billion.
A number of brokerages have issued reports on HCA. Oppenheimer increased their target price on shares of HCA Healthcare from $142.00 to $150.00 and gave the company an outperform rating in a report on Wednesday, January 30th. Leerink Swann increased their target price on shares of HCA Healthcare from $160.00 to $175.00 and gave the company an outperform rating in a report on Wednesday, January 30th. SunTrust Banks increased their target price on shares of HCA Healthcare to $175.00 and gave the company a buy rating in a report on Wednesday, January 30th. Stephens began coverage on shares of HCA Healthcare in a report on Monday, January 14th. They issued an overweight rating and a $143.00 target price for the company. Finally, ValuEngine cut shares of HCA Healthcare from a buy rating to a hold rating in a report on Wednesday, March 6th. Two analysts have rated the stock with a sell rating, three have given a hold rating and eighteen have issued a buy rating to the stock. HCA Healthcare presently has a consensus rating of Buy and a consensus price target of $149.18.
Shares of HCA opened at $124.09 on Thursday. HCA Healthcare has a 1-year low of $94.23 and a 1-year high of $147.42. The company has a market cap of $43.70 billion, a PE ratio of 12.70, a price-to-earnings-growth ratio of 1.06 and a beta of 0.75.
The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Monday, June 3rd will be given a dividend of $0.40 per share. The ex-dividend date is Friday, May 31st. This represents a $1.60 dividend on an annualized basis and a yield of 1.29%. HCA Healthcare’s dividend payout ratio (DPR) is currently 16.38%.
In related news, SVP Deborah M. Reiner sold 466 shares of the firm’s stock in a transaction that occurred on Tuesday, February 5th. The shares were sold at an average price of $139.07, for a total transaction of $64,806.62. Following the sale, the senior vice president now owns 5,037 shares in the company, valued at $700,495.59. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jon M. Foster sold 11,640 shares of the firm’s stock in a transaction that occurred on Tuesday, February 12th. The stock was sold at an average price of $139.68, for a total transaction of $1,625,875.20. Following the sale, the insider now owns 84,492 shares in the company, valued at approximately $11,801,842.56. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 77,953 shares of company stock worth $10,867,368. 2.70% of the stock is owned by company insiders.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Read More: What are Institutional Investors?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.